Many common cancer driver genes show marked tissue specificity (Haigis et al., 2019; Schneider et al., 2017) and SHP‐2 has been classified primarily as an oncogenic driver gene for sporadic hematopoietic and lymphoid neoplasms (Bailey et al., 2018; Chan & Feng, 2007). This evidence concerns the gene PTPN11 and cancer.